| Description | Atrolactamide is an anticonvulsant. |
| molecular weight | 165.19 |
| Molecular formula | C9H11NO2 |
| CAS | 2019-68-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Baum S, Williamson DS, Sewell T, Stolz A. Conversion of sterically demanding α,α-disubstituted phenylacetonitriles by the arylacetonitrilase from Pseudomonas fluorescens EBC191. Appl Environ Microbiol. 2012 Jan;78(1):48-57. doi: 10.1128/AEM.05570-11. Epub 2011 Oct 21. PubMed PMID: 22020513; PubMed Central PMCID: PMC3255610. 2. SHERROD TR, ZUBAIDI HI. Atrolactamide (themisone, M-144); its determination, absorption and excretion. J Pharmacol Exp Ther. 1953 Oct;109(2):148-56. PubMed PMID: 13097345. 3. ABDULIAN DH, SHERROD TR. Atrolactamide: its absorption, distribution and excretion. J Pharmacol Exp Ther. 1955 Apr;113(4):439-45. PubMed PMID: 14368513. 4. Schenck HA, Lenkowski PW, Choudhury-Mukherjee I, Ko SH, Stables JP, Patel MK, Brown ML. Design, synthesis and evaluation of novel hydroxyamides as orally available anticonvulsants. Bioorg Med Chem. 2004 Mar 1;12(5):979-93. PubMed PMID: 14980611. |